01-27-2009, 07:50 AM
I think this is election gimmick.
Companies allows production of generic medicine after some gap, basically after companies recovers R&D cost, patent expiry.
06 February 2008
<b>US FDA approves Ranbaxy's generic version of GlaxoSmithKline's Ceftin for US sales</b>
Sep 17, 2008
<b>Ranbaxy Generic Drugs Denied Import to U.S. by FDA Filed</b>
Within 7 month they were out
Same problem is with Dr Reddy's lab.
Companies allows production of generic medicine after some gap, basically after companies recovers R&D cost, patent expiry.
06 February 2008
<b>US FDA approves Ranbaxy's generic version of GlaxoSmithKline's Ceftin for US sales</b>
Sep 17, 2008
<b>Ranbaxy Generic Drugs Denied Import to U.S. by FDA Filed</b>
Within 7 month they were out
Same problem is with Dr Reddy's lab.